Asbestos: Profound Evidence for Disease Associations

Advancing Medicine with Food and Nutrients: Second Edition

Volumn , Issue , 2012, Pages 777-798

  Omura, Yoshiaki ^a,b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Heart Disease Research Foundation Brooklyn   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891922374     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b13694-46     Document Type: Chapter

References (100)

1. Omura, Y. “Asbestos as a possible major cause of not only malignant lung tumors (including small cell carcinoma, adenocarcinoma and mesothelioma), but also brain tumors (i.e. astrocytoma and glioblastoma multiforme), many other malignant tumors, some types of intractable pain including fibromyalgia, and some cardio-vascular pathology: Safe and effective methods of reducing asbestos from normal and pathological areas.” Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 31, pp 61-125, 2006.
2. Bueno, R., et al. “Pleural biopsy: A reliable method for determining the diagnosis but not subtype in mesothelioma.” Annals of Thoracic Surgery, Vol. 78, Nn. 5, pp. 1774-1776; 2004.
3. Johansson, L., and Lindén, C. “Aspects of histopathologic subtype as a prognostic factor in 85 pleural mesotheliomas.” Chest, Vol. 109, no. 1, pp. 109-114, 1996.
4. Omura, Y. “Important role of asbestos in intractable medical problems including malignant tumors, cardiovascular diseases, alzheimer’s disease, autism, cataracts, intractable painful substances, and morgellon’s disease: how to remove asbestos and other harmful substances from the body safely and effectively by elevating normal cell telomere to more than 500 ng (BDORT Units) - updated in 2009. Program and Abstract of 19th Annual Symposium of Japan Bi-digital O-Ring Test Medical Society, Held at Tokyo University, during July 4th-5th, 2009, pp. 15-17.
5. Mesothelioma Research Foundation of America. “Types of asbestos, " 2010. http://www.mesorfa.org/exposure/asbestos-types.php.
6. Sullivan, P.A. “Vermiculite, respiratory disease, and asbestos exposure in libby, montana: Update of a cohort mortality study.” Environmental Health Perspectives, Vol. 115, no. 4, pp. 579-585, 2007.
7. Peipins, L.A. “Radiographic abnormalities and exposure to asbestos-contaminated vermiculite in the community of Libby, Montana, USA.” Environmental Health Perspectives, Vol. 111, no., 14, pp. 1753-1759, 2003.
8. McDonald, J.C., Harris, J., and Armstrong, B.. “Mortality in a cohort of vermiculite miners exposed to fibrous amphibole in Libby, Montana.” Occupational and Environmental Medicine, Vol. 61, pp. 363-366, 2004.
9. Kellett, C.E.. “Sir Thomas Browne and the disease called the Morgellons.” Annals of Medical History, Vol. 7, pp. 467-479, 1935.
10. Koblenzer, C.S. “The challenge of Morgellons disease.” Journal of the American Academy of Dermatology, Vol. 55, no. 5, pp. 920-922, 2006.
11. Savely, V.R., Leitao, M.M., Stricker, R.B. “The mystery of Morgellons Disease: Infection or delusion?" American Journal of Clinical Dermatology, Vol. 7, no. 1, pp. 1-5(5), 2006.
12. Greaves, M.W., Khalifa, N. “Itch: More than skin deep.” International Archives of Allergy and Immunology, Vol. 135, pp. 166-172, 2004.
13. Morgellons Research Foundation Web site. Available at: http://www.morgellons.org/. Accessed January 10, 2012.
14. Savely, V.R., and Stricker, R.B. “Morgellons disease: Analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology.” Clinical, Cosmetic and Investigational Dermatology, Vol. 3, pp. 67-78, 2010.
15. Harvey, W.T., et al. “Morgellons disease, illuminating an undefined illness: A case series.” Journal of Medical Case Reports, Vol. 3, no. 1, 8243, 2009.
16. Dreifus, C. “Finding clues to aging in the fraying tips of chromosomes.” New York Times. July 3, 2007. http://www.nytimes.com/2007/07/03/science/03conv.html?pagewanted=all.
17. Takagi, A., et al. “Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multiwall carbon nanotube.” Journal of Toxicological Sciences, Vol. 33, no. 1, pp. 105-116, 2008.
18. Poland, C. A. et al. “Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study.” Nature Nanotechnology, Vol. 3, pp. 423-428, 2008.
19. Chang, Kenneth. “In study, researchers find nanotubes may pose health risks similar to asbestos.” New York Times. May 21, 2008.
20. Kane, A. B., and R. H. Hurt. “The asbestos analogy revisited.” Nature Nanotechnology, Vol. 3, pp. 378-379, 2008.
21. Donaldson, K., and C. A. Poland. “New insights into nanotubes.” Nature Nanotechnology, Vol. 4, pp. 708-710, 2009.
22. Service, R. F. “Nanotubes: The next asbestos?" Science, Vol. 281, pp. 941, 1998.
23. Poland, C. A., et al. “Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study.” Nature Nanotechnology, Vol. 3, pp. 423-428, 2008.
24. Takagi, A., et al. “Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multiwall carbon nanotube.” Journal of Toxicological Sciences, Vol. 33, no. 1, pp. 105-116, 2008.
25. Fubini, B., and Otero-Areán, C. “Chemical aspects of the toxicity of inhaled mineral dusts.” Chemical Society Reviews, Vol. 28, pp. 373-381, 1999.
26. IARC: Surgical Implants and Other Foreign Bodies. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 74: pp. 313-322 (World Health Organization, Lyon, France, 1999).
27. Marsh, G.M., et al. “Cancer mortality among man-made vitreous fiber production workers.” Epidemiology, Vol. 9, no. 2, pp. 218-220, 1998.
28. McGrath, K. “An earlier age of breast cancer diagnosis related to more frequent use of antiperspirants/deodorants and underarm shaving.” European Journal of Cancer Prevention, Vol. 12, no. 6, pp. 479-485, 2003.
29. Blue, L. “Do antiperspirants cause breast cancer?" TIME Healthland. http://healthland.time.com/2012/01/12/do-antiperspirants-cause-breast-cancer/. January 12, 2012.
30. Doheny, K. “Does deodorant ingredient affect breast cancer risk?" HealthDay. http://consumer.healthday.com/Article.asp?AID=660647. January 12, 2012.
31. Mann, D. “Are fears that deodorant causes breast cancer unfounded?" WebMD Health News. http://www.webmd.com/breast-cancer/news/20120112/are-fears-that-deodorant-causes-breast-cancerunfounded. January 12, 2012.
32. Christensen, B.C. “Epigenetic profiles, asbestos burden, and survival in pleural mesothelioma.” Dissertation/Thesis, Harvard University, 2008, 136 pages; AAT 3312317.
33. Roberts, H.C., et al. “Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure.” Journal of Thoracic Oncology, Vol. 4; iss. 5, pp 620-628, May 2009.
34. Creaney, J., et al. “Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma” Cancer Epidemiology, Biomarkers and Prevention, Vol. 19, no. 9, pp. 2238-2246, 2010.
35. Park, E., et al. “Soluble mesothelin-related protein in an asbestos-exposed population: The dust diseases board cohort study.” American Journal of Respiratory and Critical Care Medicine, Vol. 178, no. 8, pp. 832-837, 2008.
36. Hollevoet, K. “Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals: a prospective longitudinal cohort study.” Journal of Thoracic Oncology, Vol. 6, no. 5, pp. 889-895, 2011.
37. Thurneysen, C., et al. “Functional inactivation of NF2/merlin in human mesothelioma.” Lung Cancer, Vol. 64, pp. 140-147, 2009.
38. Eisenstadt, H.B. “Asbestos pleurisy.” Diseases of the Chest, Vol 46, pp. 78-81, 1964.
39. Greillier, L. and P. Astoul. “Mesothelioma and asbestos-related pleural diseases.” Respiration, Vol. 76, pp. 1-15, 2008.
40. Harber, P., Mohsenifar, Z., Oren, A., Lew, M. “Pleural plaques and asbestos-associated malignancy.” Journal of Occupational Medicine, Vol. 29, pp. 641-644, 1987.
41. Weiss, W. “Asbestos-related pleural plaques and lung cancer.” Chest, Vol. 103, pp. 1854-1859, 1993.
42. Solomon, A. “Radiological features of asbestos-related visceral pleural changes.” American Journal of Industrial Medicine, Vol. 19, pp. 339-355, 1991.
43. Bianchi, C., Bianchi, T. “Malignant mesothelioma: Global incidence and relationship with asbestos.” Industrial Health, Vol. 45, pp. 379-387, 2007.
44. Leigh, J., Davidson, P., Hendrie, L., Berry, D. “Malignant mesothelioma in Australia, 1945-2000.” American Journal of Industrial Medicine, Vol. 41, pp. 188-201, 2002.
45. McElvenny, D.M., Darnton, A.J., Price, M.J., Hodgson, J.T. “Mesothelioma mortality in Great Britain from 1968 to 2001.” Occupational Medicine (London), Vol. 55, pp. 79-87, 2005.
46. Benard, F., Sterman, D., Smith, R.J., Kaiser, L.R., Albelda, S.M., Alavi A. “Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography.” Chest, Vol. 114, pp. 713-722, 1998.
47. Flores, R.M., Akhurst, T., Gonen, M., Larson, S.M., Rusch, V.W. “Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma.” Journal of Thoracic and Cardiovascular Surgery, Vol. 126, pp. 11-16, 2003.
48. Flores, R.M., Akhurst, T., Gonen, M., Zakowski, M., Dycoco, J., Larson, S.M., Rusch, V.W. “Positron emission tomography predicts survival in malignant pleural mesothelioma.” Journal of Thoracic and Cardiovascular Surgery, Vol. 132, pp. 763-768, 2006.
49. Ceresoli, G.L., Chiti, A., Zucali, P.A., Rodari, M., Lutman, R.F., Salamina, S., Incarbone, M., Alloisio, M., Santoro, A. “Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18f]fluorodeoxyglucose.” Journal of Clinical Oncology, Vol. 24, pp. 4587-4593, 2006.
50. Bueno, R., Reblando, J., Glickman, J., Jaklitsch, M.T., Lukanich, J.M., Sugarbaker, D.J. “Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma.” Annals of Thoracic Surgery, Vol. 78, pp. 1774-1776, 2004.
51. Alatas, F., Alatas, O., Metintas, M., Colak, O., Harmanci, E., Demir, S. “Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions.” Lung Cancer, Vol. 31, pp. 9-16, 2001.
52. van den Heuvel, M.M., Korse, C.M., Bonfrer, J.M., Baas, P. “Non-invasive diagnosis of pleural malignancies: The role of tumour markers. Lung Cancer, DOI: 10.1016/j.lungcan.2007.08.030.
53. Pass, H.I., Wali, A., Tang, N., Ivanova, A., Ivanov, S., Harbut, M., Carbone, M., Allard, J. “Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions.” Annals of Thoracic Surgery, Vol. 85, pp. 265-272, discussion 272, 2008.
54. Grigoriu, B.D., Scherpereel, A., Devos, P., Chahine, B., Letourneux, M., Lebailly, P., Gregoire, M., Porte, H., Copin, M.C., Lassalle, P. “Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment.” Clinical Cancer Research, Vol. 13, pp. 2928-2935, 2007.
55. Herndon, J.E., Green, M.R., Chahinian, A.P., Corson, J.M., Suzuki, Y., Vogelzang, N.J. “Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B.” Chest, Vol. 113, pp. 723-731, 1998.
56. Raffit, H., et al. “Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer.” Clinical Cancer Research, Vol.12, pp. 447, 2006.
57. Omura, Y. “A new, simple, non-invasive imaging technique of internal organs and various cancer tissues using extended principles of the ‘Bi-Digital O-Ring Test’ without using expensive imaging instruments or exposing the patient to any undesirable radiation-Part 1.” Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 10, pp. 255-277, 1985.
58. Omura, Y. "‘Bi-Digital O-Ring Test Molecular Identification and Localization Method’ and its application in imaging of internal organs and malignant tumors as well as identification and localization of neurotransmitters and micro-organisms-Part 1.” Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 11, no. 2, pp. 65-100, 1986.
59. Omura, Y. “Re-evaluation of the classical acupuncture concept of meridians in oriental medicine by the new method of detecting meridian-like networks connected to internal organs using ‘Bi-Digital O-Ring Test.'" Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 11, pp. 219-231, 1986.
60. Omura, Y. “Electro-magnetic resonance phenomenon as a possible mechanism related to the ‘Bi-Digital O-Ring Test Molecular Identification and Localization Method.'" Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 11, no. 2, pp. 127-145, 1986.
61. Omura, Y. “Highlights of the forthcoming 1st International Symposium on Acupuncture and Electro-Therapeutics to celebrate the 10th anniversary of Acupuncture and Electro-Therapeutics Research, The International Journal., 1 Stress and Immunity and effects of stimulation of deep peroneal nerve at St.36 on ventricular arrhythmia, heart disease and sudden death. 2 New, simple, accurate and inexpensive imaging technique of internal organs and cancer tissue by a clinical application of “Bi-Digital O-Ring Test” and clinical significance of newly discovered networks of thymus glands in cancer treatment.” Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 10, pp. 1-2, 1985.
62. Omura, Y. “Simple and quick non-invasive evaluation of circulatory condition of cerebral arteries by clinical application of the ‘Bi-Digital O-Ring Test.'" Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 10, pp. 139-161, 1985.
63. Omura, Y. Editorial: “Effects of an electrical field and its polarity on an abnormal part of the body or organ representation point associated with a diseased internal organ, and its influence on the ‘Bi-Digital O-Ring Test’ (simple, non-invasive dysfunction localization method) and drug compatibility test-Part 1.” Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 7, pp. 209-246, 1982.
64. Omura, Y., Nisteruk, C.J., Losco, Bro. M., Heller, S.I., Omura, A., Cook, A., Williams, G. “Noninvasive early diagnosis of cardiovascular diseases by the combined use of the ‘Bi-Digital O-Ring Test Dysfunction Localization Method, ' organ representation points and of wide frequency bandwidth ECG’s and selective high frequency wide bandwidth ECG’s.” Japanese Heart Journal, Vol. 23, pp 564-566, supplement, 1982.
65. Omura, Y. “Application of the Bi-Digital O-Ring Test for diagnosis and effective treatment of intractable pain, infection, and cancer using selective drug-uptake enhancement methods, and the relationship between these intractable problems and harmful environmental electro-magnetic fields and localized deposits of heavy metal in the body.” 6th Congress of the Japan Bi-Digital O-Ring Test Medical Society, pp. 58-61, Tokyo University, Tokyo, Japan, 1996 Aug 8-10.
66. Shimotsura, Y., Omura, Y. “Standard laboratory test (x-ray with barium enema, colono-fiberscopic examination of the colon, and histopathological examination of pathological tissues) evaluation of 237 pathological areas of the colon where strong Bi-Digital O-Ring Test cancer positive response was found in 147 patients.” 6th Congress of the Japan Bi-Digital O-Ring Test Medical Society, p. 71, Tokyo University, Tokyo, Japan, 1996 Aug 8-10.
67. Omura, Y. “Early cancer screening and a new safe and effective cancer therapy using selective drug uptake enhancement methods, anti-viral agents, and the removal of mercury based on the Bi-Digital O-Ring Test evaluation.” 3rd International Symposium on the Bi-Digital O-Ring Test, pp. 127-128, Waseda University, Tokyo, Japan, 1997 Oct 3-5.
68. Omura, Y. “Long-term exposure to extremely high frequency electro-magnetic fields in the home or office environment, localized deposits of hg, and viral infection in individuals as major contributing factors to the genesis of cancer and cardiovascular disease.” 3rd International Symposium on the Bi-Digital O-Ring Test, pp. 129-130, Waseda University, Tokyo, Japan, 1997 Oct 3-5.
69. Omura, Y. “Major causes of intractable pain and their effective treatment using the Bi-Digital O-Ring Test: Combined use of effective anti-microbial agents, cilantro to remove heavy metals, and drug uptake enhancement method selectively deliver the drugs to the pathological areas.” 3rd International Symposium on the Bi-Digital O-Ring Test, pp. 147-148, Waseda University, Tokyo, Japan, 1997 Oct 3-5.
70. Omura, Y. “Early non-invasive cancer screening by detecting levels of integrin α5β1, oncogene C-fos Ab-2, Hg, acetylcholine, viral infection, NO, D-glucose, p53 (Ab-5) and Rb (Ab-8), and a new safe and effective cancer therapy using a mixture of EPA and DHA as an anti-viral agent, and cilantro to remove intracellular mercury and ‘Selective Drug Uptake Enhancement Method’ based on the Bi-Digital O-Ring Test evaluation.” 8th Congress of the Japan Bi-Digital O-Ring Test Medical Society, pp. 58-59, Showa University, Tokyo, Japan, 1998 Jul 19-20.
71. Omura, Y. “Electromagnetic field hypersensitivity, cancer, pre-cancer and abnormal pure (-) qi gong energy emission.” 8th Congress of the Japan Bi-Digital O-Ring Test Medical Society, pp. 60-61, Showa University, Tokyo, Japan, 1998 Jul 19-20.
72. Omura, Y. “Early non-invasive cancer screening by detecting levels of integrin α5β1, oncogene C-fos Ab-2, Hg, acetycholine, viral infection, NO, D-glucose, p53 (Ab-5) and Rb (Ab-8), and a new safe and effective cancer therapy using a mixture of EPA and DHA as an anti-viral agent, and cilantoro to remove intracellular mercury and ‘Selective Drug Uptake Enhancement Method’ based on the Bi-Digital O-Ring Test evaluation.” Presented as a guest speaker at 8th Annual Congress of Japan Bi-Digital O-Ring Test Medical Society at Showa University, Tokyo, Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 23, nos. 3 and 4, pp. 229-230, 1998.
73. Omura, Y. “Accurate organ representation areas on the face, nose, lips, and tongue localized by Bi-Digital O-Ring Test and their clinical application for diagnosis and treatment.” Presented as a guest speaker at 8th Annual Congress of Japan Bi-Digital O-Ring Test Medical Society at Showa University, Tokyo, Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 23, nos. 3 and 4, pg. 231, 1998.
74. Omura, Y., Shimotsuura, Y., Ooki, M., Noguchi, T. “Estimation of the amount of telomere molecules in different human age groups and the telomere increasing effect of acupuncture and Shiatsu on St.36, using synthesized basic units of the human telomere molecules as reference control substances for the Bi-Digital O-Ring Test resonance phenomenon.” Presented as a guest speaker at 8th Annual Congress of Japan Bi-Digital O-Ring Test Medical Society at Showa University, Tokyo, Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 23, nos. 3 and 4, pp. 185-206, 1998.
75. Omura, Y. “Non-invasive diagnosis and effective treatment of chronic intractable lower back pain using the Bi-Digital O-Ring test resonance phenomenon and the Selective Drug Uptake Enhancement Method.” Abstract published in Program and Abstract of the International Symposium: Satellite of the 9th Congress of the Pain Clinic, held in Tokyo, Japan, July 12-13, 2000, pg. 66; the paper was subsequently published in the hardcover book Management of Pain: A World Perspective, ed. H. Yanagida, K. Hanaoka, and O. Yuge, as part of the 9th International Symposium on Pain, organized by the International Association for the Study of Pain, by Monduzzi Editore, Bologna Italy, 2000, pp. 65-74.
76. Omura, Y. “Non-invasive and quick diagnostic method using the Bi-Digital O-Ring test resonance phenomenon between 2 identical substances for the early detection of cancer and effective treatment using the Selective Drug Uptake Enhancement Method.” Presented at the 16th Annual Symposium on Acupuncture and Electro Therapeutics, October 19-22, 2000, at the School of International Affairs at Columbia University, abstract published in Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 25, nos. 3-4, pp. 211-213, 2000.
77. Duvvi, H., Omura, Y. “Evaluation of the Bi-Digital O-Ring Test for the detection of precancer from rat colon photographs.” Presented at the 16th Annual Symposium on Acupuncture and Electro Therapeutics, October 19-22, 2000, at the School of International Affairs at Columbia University, abstract published in Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 25, nos. 3-4, pp. 249-250, 2000.
78. Omura, Y. “Transmission of molecular information on molecular structures and amounts of the molecules through the recorded traces of photons, sound waves, and electric currents coming through biological tissue and their clinical applications for new non-invasive diagnosis and treatment of intractable medical problems.” Presented at the 4th Biennial International Symposium on the Bi-Digital O-Ring Test, July 21-23, 2001, at Waseda University, Tokyo, Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 26, nos. 1-2, pp. 77-79, 2001.
79. Omura, Y., Tobe, Y. “Marked beneficial effects obtained after acupuncture at True St. 36 compared with very little effects obtained from acupuncture on traditional St. 36-Localization of True St. 36 and traditional St. 36 and their acupuncture effects clarified using the Bi-Digital O-Ring Test.” (In Japanese) Ido No Nippon, The Japanese Journal of Acupuncture and Manual Therapies, Serial No. 692, pp. 129-150, Oct. 2001.
80. Omura, Y., Shimotsuura, Y., Ohki, M. "2 minute non-invasive screening of heart disease and 2 minute non-invasive screening of cardio-vascular diseases, and their safe and effective treatment.” Abstract of the 5th Biennial International Symposium on the Bi-Digital O-Ring Test, pp. 36-38, organized and published by Japan Bi-Digital O-Ring Test Medical Society, held at Ibuka International Auditorium, Waseda University, Tokyo, Japan, during July 19-21, 2002, reprinted in Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 27, nos. 3 and 4, pp. 219-221, 2002.
81. Omura, Y. “Non-invasive 6-minute screening of pre-alzheimer’s disease by estimating amounts of Acetylcholine, b-Amyloid (1-42), Al, Hg and Pb of the brain, and the safe and effective treatment of pre-alzheimer’s disease using the ‘Selective Drug Uptake Enhancement Method.'" Abstract of 5th Biennial International Symposium on Bi-Digital O-Ring Test, pp. 75-76, organized and published by Japan Bi-Digital O-Ring Test Medical Society, held at Ibuka International Auditorium, Waseda University, Tokyo, Japan, during July 19-21, 2002, reprinted in Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 27, nos. 3 and 4, pp. 226-227, 2002.
82. Omura, Y., Tobe, Y. “Screening and effective treatment of alzheimer’s disease and cancer, and correct location of acupuncture points St.36 (True St.36) and Li.4 (True Li.4) and their application for the treatment of intractable diseases by using Bi-Digital O-Ring Test.” (In Japanese), Ido No Nippon. The Japanese Journal of Acupuncture and Manual Therapies, Vol 62, no. 10, pp. 81-92, Oct 2003.
83. Omura, Y. “Rapid screening and diagnosis of various cancers from human voice using Bi-Digital O-Ring Test resonance phenomenon between 2 identical substances i.e. between microscopic slide of specific cancer tissue and cancer information in the sound of human voice, and detection of myocardial damage and infection from human voice.” Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 32, nos. 3/4, pp. 235-270, 2007.
84. Shimotsuura, Y., Omura, Y. “Case reports of clinical cancer found by standard laboratory tests several years after positive findings by Bi-Digital O-Ring Test.” Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 33, nos. 1/2, pp. 54-55, 2008.
85. Omura, Y. “Organ representation areas of different internal organs localized on the eyebrows and eyelids by the Bi-Digital O-Ring Test electromagnetic resonance phenomenon between 2 identical molecules - part i: detection of increased markers for cancer and heart disease from white hairs on the eyebrows and marked decrease in the markers after taking one optimal dose of DHEA.” Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 33, nos. 3/4, pp. 193-224, 2008.
86. Omura, Y. “Comparison of effects of press-needle acupuncture, moxibustion, (+) qigong energy stored paper or (+) solar energy stored paper on True ST-36 (Omura’s ST-36) and traditional ST-36 on the amount of normal cell telomere and the anti-cancer, anti-aging and anti-alzheimer’s effects of these treatments. To be presented in May 2011 at ICMART International congress on medical acupuncture in Holland (1-page abstract in press).
87. Omura, Y., Chen, Y., Lermand, O., Jones, M., Duvvi, H., Shimtosuura, Y. “Effects of transcutaneous electrical stimulation (1 pulse/sec) through custom-made disposable surface electrodes covering Omura’s ST36 area of both legs on normal cell telomeres, oncogene C-fos Ab2, Integrin α5β1, chlamydia trachomatis, etc. in breast cancer and alzheimer patients.” Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 35, nos. 3/4, pp. 147-186, 2010.
88. Omura, Y., O’Young, B., Jones, M., Pallos, A., Duvvi, H., Shimotsuura, Y. “Caprylic acid in the effective treatment of intractable medical problems of frequent urination, incontinence, chronic upper respiratory infection, root canalled tooth infection, ALS, etc., caused by asbestos and mixed infections of Candida albicans, Helicobacter pylori, and Cytomegalovirus with or without other microorganisms and mercury.” Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 36, nos. 1/2, pp. 19-64, 2011.
89. Omura, Y. “Beneficial effects of bitter melon (goya), which excretes toxic substances, including radioactive substances, and induces weight loss and anti-aging effect.” Soukai, No. 8, pp. 148-149, 2011.
90. Omura, Y. Lu, DP., Jones, M., O’Young B., Duvvi, H., Paluch, K., Shimotsuura, Y., Ohki, M. “New clinical findings on the longevity gene in disease, health, and longevity: Sirtuin 1 often decreases with advanced age and serious diseases in most parts of the human body, while relatively high and constant sirtuin 1 regardless of age was first found in the hippocampus of supercentenarians.” Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 36, nos. 3/4, 23 page article in press, 2011.
91. Omura, Y. “Reduced glucose uptake with markedly increased gastrin releasing peptide, osteopontine and asbestos found in dark black areas of PET scan of chest wall in patient with mesothelioma.” Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 31, pp 247-257, 2006.
92. Francis, R.J., Byrne, M.J., van der Schaaf, A.A., Boucek, J.A., Nowak, A.K., Phillips, M., Price, R., Patrikeos, A.P., Musk, A.W., Millward, M.J. “Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans. Journal of Nuclear Medicine, Vol. 48, pp. 1449-1458, 2007.
93. Flores, R.M. “The role of PET in the surgical management of malignant pleural mesothelioma.” Lung Cancer, Vol. 49, suppl 1, pp. S27-S32.
94. Steinert, H.C., Santos Dellea, M.M., Burger, C., Stahel, R. “Therapy response evaluation in malignant pleural mesothelioma with integrated PET-CT imaging.” Lung Cancer, Vol. 49, suppl 1, pp. S33-S35, 2005.
95. Huff, J., Ladou, J. “Aspartame bioassay findings portend human cancer hazards.” International Journal of Occupational and Environmental Health, Vol 13: pp. 446-448; 2007.
96. Weihrauch, MR, Diehl, V. “Artificial sweeteners-do they bear a carcinogenic risk?" Annals of Oncology, Vol. 15, pp. 1460-1465, 2004.
97. Tollefson, L., Barnard, R.J. “An analysis of FDA passive surveillance reports of seizures associated with consumption of aspartame.” Journal of the American Dietetic Association, Vol. 92, no. 5, pp. 598-601, 1992.
98. Kroyer, G. “Stevioside and Stevia-sweetener in food: application, stability and interaction with food ingredients.” Journal of Consumer Protection and Food Safety, Vol. 5, no. 2: pp. 225-229, 2010.
99. “Stevia.” WebMD. 2009. http://www.webmd.com/vitamins-supplements/ingredientmono-682-STEVIA.aspx?activeIngredientId=682andactiveIngredientName=STEVIA.
100. Omura, Y., Chen, Y., Duvvi, H. “Anatomical relationship between traditional acupuncture point ST 36 and Omura’s ST 36(True ST 36) with their therapeutic effects: 1 inhibition of cancer cell division by markedly lowering cancer cell telomere while increasing normal telomere, 2 improving circulatory disturbances with reduction of abnormal increase in high triglyceride, L-Homocysstein, CRP, or Cardiac Troponin I and T in blood by the stimulation of Omura’s ST 36-Part 1" Acupuncture and Electro-Therapeutics Research, The International Journal, Vol. 32, pp. 31-70, 2007.